Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Antibody responses to Borrelia burgdorferi outer surface proteins C and F in experimentally infected Beagle dogs.

Callister SM, LaFleur RL, Jobe DA, Lovrich SD, Wasmoen TL.

J Vet Diagn Invest. 2015 Jul;27(4):526-30. doi: 10.1177/1040638715583868. Epub 2015 Jun 11.

PMID:
26069225
2.

Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

LaFleur RL, Callister SM, Dant JC, Wasmoen TL, Jobe DA, Lovrich SD.

Clin Vaccine Immunol. 2015 Jul;22(7):836-9. doi: 10.1128/CVI.00193-15. Epub 2015 May 13.

3.

Efficacy of the canine influenza virus H3N8 vaccine to decrease severity of clinical disease after cochallenge with canine influenza virus and Streptococcus equi subsp. zooepidemicus.

Larson LJ, Henningson J, Sharp P, Thiel B, Deshpande MS, Davis T, Jayappa H, Wasmoen T, Lakshmanan N, Schultz RD.

Clin Vaccine Immunol. 2011 Apr;18(4):559-64. doi: 10.1128/CVI.00500-10. Epub 2011 Feb 23.

4.

Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.

Jirjis FF, Davis T, Lane J, Carritt K, Sweeney D, Williams J, Wasmoen T.

Vet Ther. 2010 Summer;11(2):E1-6.

PMID:
20957616
5.

Transmission of canine influenza virus (H3N8) among susceptible dogs.

Jirjis FF, Deshpande MS, Tubbs AL, Jayappa H, Lakshmanan N, Wasmoen TL.

Vet Microbiol. 2010 Aug 26;144(3-4):303-9. doi: 10.1016/j.vetmic.2010.02.029. Epub 2010 Mar 3.

PMID:
20347235
6.

One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

LaFleur RL, Callister SM, Dant JC, Jobe DA, Lovrich SD, Warner TF, Wasmoen TL, Schell RF.

Clin Vaccine Immunol. 2010 May;17(5):870-4. doi: 10.1128/CVI.00524-09. Epub 2010 Mar 17.

7.

Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge.

Deshpande MS, Jirjis FF, Tubbs AL, Jayappa H, Sweeney D, Spencer SJ, Lakshmanan N, Wasmoen TL.

Vet Ther. 2009 Fall;10(3):103-12.

PMID:
20037964
8.

Experimental reproduction of canine influenza virus H3N8 infection in young puppies.

Deshpande M, Abdelmagid O, Tubbs A, Jayappa H, Wasmoen T.

Vet Ther. 2009 Spring-Summer;10(1-2):29-39.

PMID:
19742446
9.
10.

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF.

Clin Vaccine Immunol. 2009 Feb;16(2):253-9. doi: 10.1128/CVI.00373-08. Epub 2008 Dec 3.

12.
13.

Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.

Yang JS, English RV, Ritchey JW, Davidson MG, Wasmoen T, Levy JK, Gebhard DH, Tompkins MB, Tompkins WA.

J Virol. 1996 May;70(5):3011-7.

14.

Efficacy of an inactivated feline leukemia virus vaccine.

Hoover EA, Mullins JI, Chu HJ, Wasmoen TL.

AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):379-83. Review.

PMID:
8882314
15.

Development and testing of an inactivated feline leukemia virus vaccine.

Hoover EA, Mullins JI, Chu HJ, Wasmoen TL.

Semin Vet Med Surg (Small Anim). 1995 Nov;10(4):238-43.

PMID:
8820598
16.

Efficacy of an inactivated vaccine against clinical disease caused by canine coronavirus.

Fulker R, Wasmoen T, Atchison R, Chu HJ, Acree W.

Adv Exp Med Biol. 1995;380:229-34.

PMID:
8830484
17.
18.

Transmission of feline immunodeficiency virus from infected queens to kittens.

Wasmoen T, Armiger-Luhman S, Egan C, Hall V, Chu HJ, Chavez L, Acree W.

Vet Immunol Immunopathol. 1992 Dec;35(1-2):83-93.

PMID:
1337404
19.

Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome.

Vernof KK, Benirschke K, Kephart GM, Wasmoen TL, Gleich GJ.

Am J Obstet Gynecol. 1992 Nov;167(5):1355-63.

PMID:
1442990
20.

Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin.

Chu HJ, Chavez LG Jr, Blumer BM, Sebring RW, Wasmoen TL, Acree WM.

J Am Vet Med Assoc. 1992 Aug 1;201(3):403-11.

PMID:
1506244
21.

Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis.

Wasmoen TL, Sebring RW, Blumer BM, Chavez LG Jr, Chu HJ, Acree WM.

J Am Vet Med Assoc. 1992 Aug 1;201(3):412-8.

PMID:
1307866
22.

Spirochetes: vaccines, animal models and diagnostics.

Simon M, Milward F, Lefebvre R, Schouls L, Fikrig E, Wasmoen T, Stover K, Menefee B, Robinson J.

Res Microbiol. 1992 Jul-Aug;143(6):641-7. Review.

PMID:
1475524
23.

Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys.

Wasmoen TL, Wagner JM, Bartemes KR, Gleich GJ.

Placenta. 1992 May-Jun;13(3):265-72.

PMID:
1635912
24.

Association of immunoreactive eosinophil major basic protein with placental septa and cysts.

Wasmoen TL, Coulam CB, Benirschke K, Gleich GJ.

Am J Obstet Gynecol. 1991 Aug;165(2):416-20.

PMID:
1872350
25.

Evidence of eosinophil granule major basic protein in human placenta.

Wasmoen TL, McKean DJ, Benirschke K, Coulam CB, Gleich GJ.

J Exp Med. 1989 Dec 1;170(6):2051-63.

26.

Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein.

Wasmoen TL, Bell MP, Loegering DA, Gleich GJ, Prendergast FG, McKean DJ.

J Biol Chem. 1988 Sep 5;263(25):12559-63.

27.

Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins.

Wasmoen TL, Kakach LT, Collett MS.

Virology. 1988 Sep;166(1):275-80.

PMID:
3046119
28.
29.

Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor.

Wasmoen TL, Coulam CB, Leiferman KM, Gleich GJ.

Proc Natl Acad Sci U S A. 1987 May;84(9):3029-32.

30.
31.

Major basic protein as a predictor of preterm labor: a preliminary report.

Coulam CB, Wasmoen T, Creasy R, Siiteri P, Gleich G.

Am J Obstet Gynecol. 1987 Apr;156(4):790-6.

PMID:
3578393

Supplemental Content

Loading ...
Support Center